<?xml version="1.0" encoding="UTF-8"?>
<Label drug="uloric" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    6 ADVERSE REACTIONS

  EXCERPT:   Adverse reactions occurring in at least 1% of ULORIC-treated patients, and at least 0.5% greater than placebo, are liver function abnormalities, nausea, arthralgia, and rash. (  6.1  )



      



   To report SUSPECTED ADVERSE REACTIONS, contact Takeda Pharmaceuticals at 1-877-TAKEDA-7 (1-877-825-3327) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.  



 

  6.1 Clinical Trials Experience

  Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.



 A total of 2757 subjects with hyperuricemia and gout were treated with ULORIC 40 mg or 80 mg daily in clinical studies. For ULORIC 40 mg, 559 patients were treated for &gt;=6 months. For ULORIC 80 mg, 1377 subjects were treated for &gt;=6 months, 674 patients were treated for &gt;=1 year and 515 patients were treated for &gt;=2 years.



   Most Common Adverse Reactions  



 In three randomized, controlled clinical studies (Studies 1, 2 and 3), which were six to 12 months in duration, the following adverse reactions were reported by the treating physician as related to study drug. Table 1 summarizes adverse reactions reported at a rate of at least 1% in ULORIC treatment groups and at least 0.5% greater than placebo.




  Table 1: Adverse Reactions Occurring in &gt;=1% of ULORIC-Treated Patients and at Least 0.5%Greater than Seen in Patients Receiving Placebo in Controlled Studies    
  Adverse Reactions              Placebo                        ULORIC          allopurinolOf the subjects who received allopurinol, 10 received 100 mg, 145 received 200 mg, and 1122 received 300 mg, based on level of renal impairment.    
  (N=134)                        40 mg daily(N=757)             80 mg daily(N=1279)    (N=1277)        
  Liver Function Abnormalities    0.7%                           6.6%            4.6%            4.2%             
  Nausea                         0.7%                           1.1%            1.3%            0.8%             
  Arthralgia                      0%                            1.1%            0.7%            0.7%             
  Rash                           0.7%                           0.5%            1.6%            1.6%             
           The most common adverse reaction leading to discontinuation from therapy was liver function abnormalities in 1.8% of ULORIC 40 mg, 1.2% of ULORIC 80 mg, and in 0.9% of allopurinol-treated subjects.
 

 In addition to the adverse reactions presented in Table 1, dizziness was reported in more than 1% of ULORIC-treated subjects although not at a rate more than 0.5% greater than placebo.



   Less Common Adverse Reactions  



 In Phase 2 and 3 clinical studies the following adverse reactions occurred in less than 1% of subjects and in more than one subject treated with doses ranging from 40 mg to 240 mg of ULORIC. This list also includes adverse reactions (less than 1% of subjects) associated with organ systems from Warnings and Precautions.



   Blood and Lymphatic System Disorders  : anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia.



   Cardiac Disorders  : angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia.



   Ear and Labyrinth Disorders  : deafness, tinnitus, vertigo.



   Eye Disorders  : vision blurred.



   Gastrointestinal Disorders  : abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting.



   General Disorders and Administration Site Conditions  : asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst.



   Hepatobiliary Disorders  : cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly.



   Immune System Disorder  : hypersensitivity.



   Infections and Infestations  : herpes zoster.



   Procedural Complications  : contusion.



   Metabolism and Nutrition Disorders  : anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased.



   Musculoskeletal and Connective Tissue Disorders  : arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia.



   Nervous System Disorders  : altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor.



   Psychiatric Disorders  : agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change.



   Renal and Urinary Disorders  : hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence.



   Reproductive System and Breast Changes  : breast pain, erectile dysfunction, gynecomastia.



   Respiratory, Thoracic and Mediastinal Disorders  : bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection.



   Skin and Subcutaneous Tissue Disorders  : alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis  ,  peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria.



   Vascular Disorders  : flushing, hot flush, hypertension, hypotension.



   Laboratory Parameters:  activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein.



   Cardiovascular Safety  



 Cardiovascular events and deaths were adjudicated to one of the pre-defined endpoints from the Anti-Platelet Trialists' Collaborations (APTC) (cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke) in the randomized controlled and long-term extension studies. In the Phase 3 randomized controlled studies, the incidences of adjudicated APTC events per 100 patient-years of exposure were: Placebo 0 (95% CI 0.00-6.16), ULORIC 40 mg 0 (95% CI 0.00-1.08), ULORIC 80 mg 1.09 (95% CI 0.44-2.24), and allopurinol 0.60 (95% CI 0.16-1.53).



 In the long-term extension studies, the incidences of adjudicated APTC events were: ULORIC 80 mg 0.97 (95% CI 0.57-1.56), and allopurinol 0.58 (95% CI 0.02-3.24).



 Overall, a higher rate of APTC events was observed in ULORIC than in allopurinol-treated patients. A causal relationship with ULORIC has not been established. Monitor for signs and symptoms of MI and stroke.



   6.2 Postmarketing Experience

  Adverse reactions have been identified during postapproval use of ULORIC. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship.



   Hepatobiliary Disorders:  hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder.



   Immune System Disorders:  anaphylaxis, anaphylactic reaction.



   Musculoskeletal and Connective Tissue Disorders:  rhabdomyolysis.



   Psychiatric Disorders:  psychotic behavior including aggressive thoughts.



   Renal and Urinary Disorders:  tubulointerstitial nephritis.



   Skin and Subcutaneous Tissue Disorders:  generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions.
</Section>
    <Section name="warnings and precautions" id="S2">    5 WARNINGS AND PRECAUTIONS



   EXCERPT:    *     Gout Flare : An increase in gout flares is frequently observed during initiation of anti-hyperuricemic agents, including ULORIC. If a gout flare occurs during treatment, ULORIC need not be discontinued. Prophylactic therapy (i.e., non-steroidal anti-inflammatory drug [NSAID] or colchicine upon initiation of treatment) may be beneficial for up to six months. (  2.4  ,  5.1  ) 
 *     Cardiovascular Events : A higher rate of cardiovascular thromboembolic events was observed in patients treated with ULORIC than allopurinol in clinical trials. Monitor for signs and symptoms of MI and stroke. (  5.2  ) 
 *     Hepatic Effects: Postmarketing reports of hepatic failure, sometimes fatal. Causality cannot be excluded. If liver injury is detected, promptly interrupt ULORIC and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart ULORIC if liver injury is confirmed and no alternate etiology can be found. (  5.3  ) 
    
 

   5.1 Gout Flare



  After initiation of ULORIC, an increase in gout flares is frequently observed. This increase is due to reduction in serum uric acid levels, resulting in mobilization of urate from tissue deposits.



 In order to prevent gout flares when ULORIC is initiated, concurrent prophylactic treatment with an NSAID or colchicine is recommended [see  Dosage and Administration (2.4)  ].  



    5.2 Cardiovascular Events



  In the randomized controlled studies, there was a higher rate of cardiovascular thromboembolic events (cardiovascular deaths, non-fatal myocardial infarctions, and non-fatal strokes) in patients treated with ULORIC (0.74 per 100 P-Y [95% Confidence Interval (CI) 0.36-1.37]) than allopurinol (0.60 per 100 P-Y [95% CI 0.16-1.53]) [see  Adverse Reactions (6.1)  ]  . A causal relationship with ULORIC has not been established. Monitor for signs and symptoms of myocardial infarction (MI) and stroke.



    5.3 Hepatic Effects



   There have been postmarketing reports of fatal and non-fatal hepatic failure in patients taking ULORIC, although the reports contain insufficient information necessary to establish the probable cause. During randomized controlled studies, transaminase elevations greater than three times the upper limit of normal (ULN) were observed (AST: 2%, 2%, and ALT: 3%, 2% in ULORIC and allopurinol-treated patients, respectively). No dose-effect relationship for these transaminase elevations was noted [see        Clinical Pharmacology (12.3)   ]     .  



  Obtain a liver test panel (serum alanine aminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase, and total bilirubin) as a baseline before initiating ULORIC.  



  Measure liver tests promptly in patients who report symptoms that may indicate liver injury, including fatigue, anorexia, right upper abdominal discomfort, dark urine or jaundice. In this clinical context, if the patient is found to have abnormal liver tests (ALT greater than three times the upper limit of the reference range), ULORIC treatment should be interrupted and investigation done to establish the probable cause. ULORIC should not be restarted in these patients without another explanation for the liver test abnormalities.  



  Patients who have serum ALT greater than three times the reference range with serum total bilirubin greater than two times the reference range without alternative etiologies are at risk for severe drug-induced liver injury and should not be restarted on ULORIC. For patients with lesser elevations of serum ALT or bilirubin and with an alternate probable cause, treatment with ULORIC can be used with caution.  
</Section>
  </Text>
  <Mentions>
    <Mention id="M1" section="S1" type="AdverseReaction" start="153" len="28" str="liver function abnormalities" />
    <Mention id="M2" section="S1" type="AdverseReaction" start="183" len="6" str="nausea" />
    <Mention id="M3" section="S1" type="AdverseReaction" start="191" len="10" str="arthralgia" />
    <Mention id="M4" section="S1" type="AdverseReaction" start="207" len="4" str="rash" />
    <Mention id="M5" section="S1" type="AdverseReaction" start="1936" len="28" str="Liver Function Abnormalities" />
    <Mention id="M6" section="S1" type="AdverseReaction" start="2051" len="6" str="Nausea" />
    <Mention id="M7" section="S1" type="AdverseReaction" start="2165" len="10" str="Arthralgia" />
    <Mention id="M8" section="S1" type="AdverseReaction" start="2279" len="4" str="Rash" />
    <Mention id="M9" section="S1" type="AdverseReaction" start="2479" len="28" str="liver function abnormalities" />
    <Mention id="M10" section="S1" type="AdverseReaction" start="2663" len="9" str="dizziness" />
    <Mention id="M11" section="S1" type="AdverseReaction" start="3198" len="6" str="anemia" />
    <Mention id="M12" section="S1" type="AdverseReaction" start="3206" len="35" str="idiopathic thrombocytopenic purpura" />
    <Mention id="M13" section="S1" type="AdverseReaction" start="3243" len="12" str="leukocytosis" />
    <Mention id="M14" section="S1" type="AdverseReaction" start="3256" len="10" str="leukopenia" />
    <Mention id="M15" section="S1" type="AdverseReaction" start="3268" len="11" str="neutropenia" />
    <Mention id="M16" section="S1" type="AdverseReaction" start="3281" len="12" str="pancytopenia" />
    <Mention id="M17" section="S1" type="AdverseReaction" start="3295" len="12" str="splenomegaly" />
    <Mention id="M18" section="S1" type="AdverseReaction" start="3309" len="16" str="thrombocytopenia" />
    <Mention id="M19" section="S1" type="AdverseReaction" start="3354" len="15" str="angina pectoris" />
    <Mention id="M20" section="S1" type="AdverseReaction" start="3371" len="19" str="atrial fibrillation" />
    <Mention id="M21" section="S1" type="AdverseReaction" start="3371,3391" len="6,7" str="atrial flutter" />
    <Mention id="M22" section="S1" type="AdverseReaction" start="3400" len="14" str="cardiac murmur" />
    <Mention id="M23" section="S1" type="AdverseReaction" start="3416" len="12" str="ECG abnormal" />
    <Mention id="M24" section="S1" type="AdverseReaction" start="3430" len="12" str="palpitations" />
    <Mention id="M25" section="S1" type="AdverseReaction" start="3444" len="17" str="sinus bradycardia" />
    <Mention id="M26" section="S1" type="AdverseReaction" start="3463" len="11" str="tachycardia" />
    <Mention id="M27" section="S1" type="AdverseReaction" start="3513" len="8" str="deafness" />
    <Mention id="M28" section="S1" type="AdverseReaction" start="3523" len="8" str="tinnitus" />
    <Mention id="M29" section="S1" type="AdverseReaction" start="3533" len="7" str="vertigo" />
    <Mention id="M30" section="S1" type="AdverseReaction" start="3565" len="14" str="vision blurred" />
    <Mention id="M31" section="S1" type="AdverseReaction" start="3617" len="20" str="abdominal distention" />
    <Mention id="M32" section="S1" type="AdverseReaction" start="3639" len="14" str="abdominal pain" />
    <Mention id="M33" section="S1" type="AdverseReaction" start="3655" len="12" str="constipation" />
    <Mention id="M34" section="S1" type="AdverseReaction" start="3669" len="9" str="dry mouth" />
    <Mention id="M35" section="S1" type="AdverseReaction" start="3680" len="9" str="dyspepsia" />
    <Mention id="M36" section="S1" type="AdverseReaction" start="3691" len="10" str="flatulence" />
    <Mention id="M37" section="S1" type="AdverseReaction" start="3703" len="15" str="frequent stools" />
    <Mention id="M38" section="S1" type="AdverseReaction" start="3720" len="9" str="gastritis" />
    <Mention id="M39" section="S1" type="AdverseReaction" start="3731" len="31" str="gastroesophageal reflux disease" />
    <Mention id="M40" section="S1" type="AdverseReaction" start="3764" len="27" str="gastrointestinal discomfort" />
    <Mention id="M41" section="S1" type="AdverseReaction" start="3793" len="13" str="gingival pain" />
    <Mention id="M42" section="S1" type="AdverseReaction" start="3808" len="12" str="haematemesis" />
    <Mention id="M43" section="S1" type="AdverseReaction" start="3822" len="16" str="hyperchlorhydria" />
    <Mention id="M44" section="S1" type="AdverseReaction" start="3840" len="12" str="hematochezia" />
    <Mention id="M45" section="S1" type="AdverseReaction" start="3854" len="16" str="mouth ulceration" />
    <Mention id="M46" section="S1" type="AdverseReaction" start="3872" len="12" str="pancreatitis" />
    <Mention id="M47" section="S1" type="AdverseReaction" start="3886" len="12" str="peptic ulcer" />
    <Mention id="M48" section="S1" type="AdverseReaction" start="3900" len="8" str="vomiting" />
    <Mention id="M49" section="S1" type="AdverseReaction" start="3972" len="8" str="asthenia" />
    <Mention id="M50" section="S1" type="AdverseReaction" start="3982" len="10" str="chest pain" />
    <Mention id="M51" section="S1" type="AdverseReaction" start="3982,3993" len="5,10" str="chest discomfort" />
    <Mention id="M52" section="S1" type="AdverseReaction" start="4005" len="5" str="edema" />
    <Mention id="M53" section="S1" type="AdverseReaction" start="4012" len="7" str="fatigue" />
    <Mention id="M54" section="S1" type="AdverseReaction" start="4021" len="16" str="feeling abnormal" />
    <Mention id="M55" section="S1" type="AdverseReaction" start="4039" len="16" str="gait disturbance" />
    <Mention id="M56" section="S1" type="AdverseReaction" start="4057" len="23" str="influenza-like symptoms" />
    <Mention id="M57" section="S1" type="AdverseReaction" start="4082" len="4" str="mass" />
    <Mention id="M58" section="S1" type="AdverseReaction" start="4088" len="4" str="pain" />
    <Mention id="M59" section="S1" type="AdverseReaction" start="4094" len="6" str="thirst" />
    <Mention id="M60" section="S1" type="AdverseReaction" start="4135" len="14" str="cholelithiasis" />
    <Mention id="M61" section="S1" type="AdverseReaction" start="4150" len="13" str="cholecystitis" />
    <Mention id="M62" section="S1" type="AdverseReaction" start="4165" len="17" str="hepatic steatosis" />
    <Mention id="M63" section="S1" type="AdverseReaction" start="4184" len="9" str="hepatitis" />
    <Mention id="M64" section="S1" type="AdverseReaction" start="4195" len="12" str="hepatomegaly" />
    <Mention id="M65" section="S1" type="AdverseReaction" start="4241" len="16" str="hypersensitivity" />
    <Mention id="M66" section="S1" type="AdverseReaction" start="4296" len="13" str="herpes zoster" />
    <Mention id="M67" section="S1" type="AdverseReaction" start="4345" len="9" str="contusion" />
    <Mention id="M68" section="S1" type="AdverseReaction" start="4400" len="8" str="anorexia" />
    <Mention id="M69" section="S1" type="AdverseReaction" start="4410" len="18" str="appetite decreased" />
    <Mention id="M70" section="S1" type="AdverseReaction" start="4410,4429" len="8,9" str="appetite increased" />
    <Mention id="M71" section="S1" type="AdverseReaction" start="4440" len="11" str="dehydration" />
    <Mention id="M72" section="S1" type="AdverseReaction" start="4453" len="17" str="diabetes mellitus" />
    <Mention id="M73" section="S1" type="AdverseReaction" start="4472" len="20" str="hypercholesterolemia" />
    <Mention id="M74" section="S1" type="AdverseReaction" start="4494" len="13" str="hyperglycemia" />
    <Mention id="M75" section="S1" type="AdverseReaction" start="4509" len="14" str="hyperlipidemia" />
    <Mention id="M76" section="S1" type="AdverseReaction" start="4525" len="20" str="hypertriglyceridemia" />
    <Mention id="M77" section="S1" type="AdverseReaction" start="4547" len="11" str="hypokalemia" />
    <Mention id="M78" section="S1" type="AdverseReaction" start="4560" len="16" str="weight decreased" />
    <Mention id="M79" section="S1" type="AdverseReaction" start="4560,4577" len="6,9" str="weight increased" />
    <Mention id="M80" section="S1" type="AdverseReaction" start="4645" len="9" str="arthritis" />
    <Mention id="M81" section="S1" type="AdverseReaction" start="4656" len="15" str="joint stiffness" />
    <Mention id="M82" section="S1" type="AdverseReaction" start="4673" len="14" str="joint swelling" />
    <Mention id="M83" section="S1" type="AdverseReaction" start="4689" len="13" str="muscle spasms" />
    <Mention id="M84" section="S1" type="AdverseReaction" start="4689,4703" len="6,9" str="muscle twitching" />
    <Mention id="M85" section="S1" type="AdverseReaction" start="4689,4713" len="6,9" str="muscle tightness" />
    <Mention id="M86" section="S1" type="AdverseReaction" start="4689,4723" len="6,8" str="muscle weakness" />
    <Mention id="M87" section="S1" type="AdverseReaction" start="4733" len="20" str="musculoskeletal pain" />
    <Mention id="M88" section="S1" type="AdverseReaction" start="4733,4754" len="15,9" str="musculoskeletal stiffness" />
    <Mention id="M89" section="S1" type="AdverseReaction" start="4765" len="7" str="myalgia" />
    <Mention id="M90" section="S1" type="AdverseReaction" start="4808" len="13" str="altered taste" />
    <Mention id="M91" section="S1" type="AdverseReaction" start="4823" len="16" str="balance disorder" />
    <Mention id="M92" section="S1" type="AdverseReaction" start="4841" len="24" str="cerebrovascular accident" />
    <Mention id="M93" section="S1" type="AdverseReaction" start="4867" len="23" str="Guillain-Barre syndrome" />
    <Mention id="M94" section="S1" type="AdverseReaction" start="4892" len="8" str="headache" />
    <Mention id="M95" section="S1" type="AdverseReaction" start="4902" len="11" str="hemiparesis" />
    <Mention id="M96" section="S1" type="AdverseReaction" start="4915" len="12" str="hypoesthesia" />
    <Mention id="M97" section="S1" type="AdverseReaction" start="4929" len="8" str="hyposmia" />
    <Mention id="M98" section="S1" type="AdverseReaction" start="4939" len="18" str="lacunar infarction" />
    <Mention id="M99" section="S1" type="AdverseReaction" start="4959" len="8" str="lethargy" />
    <Mention id="M100" section="S1" type="AdverseReaction" start="4969" len="17" str="mental impairment" />
    <Mention id="M101" section="S1" type="AdverseReaction" start="4988" len="8" str="migraine" />
    <Mention id="M102" section="S1" type="AdverseReaction" start="4998" len="11" str="paresthesia" />
    <Mention id="M103" section="S1" type="AdverseReaction" start="5011" len="10" str="somnolence" />
    <Mention id="M104" section="S1" type="AdverseReaction" start="5023" len="25" str="transient ischemic attack" />
    <Mention id="M105" section="S1" type="AdverseReaction" start="5050" len="6" str="tremor" />
    <Mention id="M106" section="S1" type="AdverseReaction" start="5089" len="9" str="agitation" />
    <Mention id="M107" section="S1" type="AdverseReaction" start="5100" len="7" str="anxiety" />
    <Mention id="M108" section="S1" type="AdverseReaction" start="5109" len="10" str="depression" />
    <Mention id="M109" section="S1" type="AdverseReaction" start="5121" len="8" str="insomnia" />
    <Mention id="M110" section="S1" type="AdverseReaction" start="5131" len="12" str="irritability" />
    <Mention id="M111" section="S1" type="AdverseReaction" start="5145" len="16" str="libido decreased" />
    <Mention id="M112" section="S1" type="AdverseReaction" start="5163" len="11" str="nervousness" />
    <Mention id="M113" section="S1" type="AdverseReaction" start="5176" len="12" str="panic attack" />
    <Mention id="M114" section="S1" type="AdverseReaction" start="5190" len="18" str="personality change" />
    <Mention id="M115" section="S1" type="AdverseReaction" start="5226,5337" len="7,7" str="Urinary urgency" />
    <Mention id="M116" section="S1" type="AdverseReaction" start="5226,5346" len="7,12" str="Urinary incontinence" />
    <Mention id="M117" section="S1" type="AdverseReaction" start="5247" len="9" str="hematuria" />
    <Mention id="M118" section="S1" type="AdverseReaction" start="5258" len="15" str="nephrolithiasis" />
    <Mention id="M119" section="S1" type="AdverseReaction" start="5275" len="11" str="pollakiuria" />
    <Mention id="M120" section="S1" type="AdverseReaction" start="5288" len="11" str="proteinuria" />
    <Mention id="M121" section="S1" type="AdverseReaction" start="5301" len="13" str="renal failure" />
    <Mention id="M122" section="S1" type="AdverseReaction" start="5316" len="19" str="renal insufficiency" />
    <Mention id="M123" section="S1" type="AdverseReaction" start="5408" len="11" str="breast pain" />
    <Mention id="M124" section="S1" type="AdverseReaction" start="5421" len="20" str="erectile dysfunction" />
    <Mention id="M125" section="S1" type="AdverseReaction" start="5443" len="12" str="gynecomastia" />
    <Mention id="M126" section="S1" type="AdverseReaction" start="5514" len="10" str="bronchitis" />
    <Mention id="M127" section="S1" type="AdverseReaction" start="5526" len="5" str="cough" />
    <Mention id="M128" section="S1" type="AdverseReaction" start="5533" len="7" str="dyspnea" />
    <Mention id="M129" section="S1" type="AdverseReaction" start="5542" len="9" str="epistaxis" />
    <Mention id="M130" section="S1" type="AdverseReaction" start="5553" len="13" str="nasal dryness" />
    <Mention id="M131" section="S1" type="AdverseReaction" start="5568" len="30" str="paranasal sinus hypersecretion" />
    <Mention id="M132" section="S1" type="AdverseReaction" start="5600" len="16" str="pharyngeal edema" />
    <Mention id="M133" section="S1" type="AdverseReaction" start="5618" len="28" str="respiratory tract congestion" />
    <Mention id="M134" section="S1" type="AdverseReaction" start="5648" len="8" str="sneezing" />
    <Mention id="M135" section="S1" type="AdverseReaction" start="5658" len="17" str="throat irritation" />
    <Mention id="M136" section="S1" type="AdverseReaction" start="5677" len="33" str="upper respiratory tract infection" />
    <Mention id="M137" section="S1" type="AdverseReaction" start="5760" len="8" str="alopecia" />
    <Mention id="M138" section="S1" type="AdverseReaction" start="5770" len="11" str="angio-edema" />
    <Mention id="M139" section="S1" type="AdverseReaction" start="5783" len="10" str="dermatitis" />
    <Mention id="M140" section="S1" type="AdverseReaction" start="5795" len="13" str="dermographism" />
    <Mention id="M141" section="S1" type="AdverseReaction" start="5810" len="10" str="ecchymosis" />
    <Mention id="M142" section="S1" type="AdverseReaction" start="5822" len="6" str="eczema" />
    <Mention id="M143" section="S1" type="AdverseReaction" start="5830" len="18" str="hair color changes" />
    <Mention id="M144" section="S1" type="AdverseReaction" start="5850" len="20" str="hair growth abnormal" />
    <Mention id="M145" section="S1" type="AdverseReaction" start="5872" len="13" str="hyperhidrosis" />
    <Mention id="M146" section="S1" type="AdverseReaction" start="5890" len="12" str="peeling skin" />
    <Mention id="M147" section="S1" type="AdverseReaction" start="5904" len="9" str="petechiae" />
    <Mention id="M148" section="S1" type="AdverseReaction" start="5915" len="16" str="photosensitivity" />
    <Mention id="M149" section="S1" type="AdverseReaction" start="5933" len="8" str="pruritus" />
    <Mention id="M150" section="S1" type="AdverseReaction" start="5943" len="7" str="purpura" />
    <Mention id="M151" section="S1" type="AdverseReaction" start="5952" len="18" str="skin discoloration" />
    <Mention id="M152" section="S1" type="AdverseReaction" start="5952,5971" len="4,20" str="skin altered pigmentation" />
    <Mention id="M153" section="S1" type="AdverseReaction" start="5993" len="11" str="skin lesion" />
    <Mention id="M154" section="S1" type="AdverseReaction" start="6006" len="18" str="skin odor abnormal" />
    <Mention id="M155" section="S1" type="AdverseReaction" start="6026" len="9" str="urticaria" />
    <Mention id="M156" section="S1" type="AdverseReaction" start="6065" len="8" str="flushing" />
    <Mention id="M157" section="S1" type="AdverseReaction" start="6075" len="9" str="hot flush" />
    <Mention id="M158" section="S1" type="AdverseReaction" start="6086" len="12" str="hypertension" />
    <Mention id="M159" section="S1" type="AdverseReaction" start="6100" len="11" str="hypotension" />
    <Mention id="M160" section="S1" type="AdverseReaction" start="6143" len="47" str="activated partial thromboplastin time prolonged" />
    <Mention id="M161" section="S1" type="AdverseReaction" start="6192" len="18" str="creatine increased" />
    <Mention id="M162" section="S1" type="AdverseReaction" start="6212" len="21" str="bicarbonate decreased" />
    <Mention id="M163" section="S1" type="AdverseReaction" start="6235" len="16" str="sodium increased" />
    <Mention id="M164" section="S1" type="AdverseReaction" start="6253" len="12" str="EEG abnormal" />
    <Mention id="M165" section="S1" type="AdverseReaction" start="6267" len="17" str="glucose increased" />
    <Mention id="M166" section="S1" type="AdverseReaction" start="6286" len="21" str="cholesterol increased" />
    <Mention id="M167" section="S1" type="AdverseReaction" start="6309" len="23" str="triglycerides increased" />
    <Mention id="M168" section="S1" type="AdverseReaction" start="6334" len="17" str="amylase increased" />
    <Mention id="M169" section="S1" type="AdverseReaction" start="6353" len="19" str="potassium increased" />
    <Mention id="M170" section="S1" type="AdverseReaction" start="6374" len="13" str="TSH increased" />
    <Mention id="M171" section="S1" type="AdverseReaction" start="6389" len="24" str="platelet count decreased" />
    <Mention id="M172" section="S1" type="AdverseReaction" start="6415" len="20" str="hematocrit decreased" />
    <Mention id="M173" section="S1" type="AdverseReaction" start="6437" len="20" str="hemoglobin decreased" />
    <Mention id="M174" section="S1" type="AdverseReaction" start="6459" len="13" str="MCV increased" />
    <Mention id="M175" section="S1" type="AdverseReaction" start="6474" len="13" str="RBC decreased" />
    <Mention id="M176" section="S1" type="AdverseReaction" start="6489" len="20" str="creatinine increased" />
    <Mention id="M177" section="S1" type="AdverseReaction" start="6511" len="20" str="blood urea increased" />
    <Mention id="M178" section="S1" type="AdverseReaction" start="6533" len="30" str="BUN/creatinine ratio increased" />
    <Mention id="M179" section="S1" type="AdverseReaction" start="6565,6594" len="22,9" str="creatine phosphokinase increased" />
    <Mention id="M180" section="S1" type="AdverseReaction" start="6589,6594" len="3,9" str="CPK increased" />
    <Mention id="M181" section="S1" type="AdverseReaction" start="6605" len="30" str="alkaline phosphatase increased" />
    <Mention id="M182" section="S1" type="AdverseReaction" start="6637" len="13" str="LDH increased" />
    <Mention id="M183" section="S1" type="AdverseReaction" start="6652" len="13" str="PSA increased" />
    <Mention id="M184" section="S1" type="AdverseReaction" start="6667" len="22" str="urine output increased" />
    <Mention id="M185" section="S1" type="AdverseReaction" start="6667,6690" len="12,9" str="urine output decreased" />
    <Mention id="M186" section="S1" type="AdverseReaction" start="6701" len="26" str="lymphocyte count decreased" />
    <Mention id="M187" section="S1" type="AdverseReaction" start="6729" len="26" str="neutrophil count decreased" />
    <Mention id="M188" section="S1" type="AdverseReaction" start="6757" len="13" str="WBC increased" />
    <Mention id="M189" section="S1" type="AdverseReaction" start="6757,6771" len="3,9" str="WBC decreased" />
    <Mention id="M190" section="S1" type="AdverseReaction" start="6782" len="25" str="coagulation test abnormal" />
    <Mention id="M191" section="S1" type="AdverseReaction" start="6809,6839" len="23,9" str="low density lipoprotein increased" />
    <Mention id="M192" section="S1" type="AdverseReaction" start="6834,6839" len="3,9" str="LDL increased" />
    <Mention id="M193" section="S1" type="AdverseReaction" start="6850" len="26" str="prothrombin time prolonged" />
    <Mention id="M194" section="S1" type="AdverseReaction" start="6878" len="13" str="urinary casts" />
    <Mention id="M195" section="S1" type="AdverseReaction" start="6893" len="36" str="urine positive for white blood cells" />
    <Mention id="M196" section="S1" type="AdverseReaction" start="6893,6934" len="18,7" str="urine positive for protein" />
    <Mention id="M197" section="S1" type="AdverseReaction" start="6977" len="21" str="Cardiovascular events" />
    <Mention id="M198" section="S1" type="AdverseReaction" start="7003" len="6" str="deaths" />
    <Mention id="M199" section="S1" type="AdverseReaction" start="7120" len="20" str="cardiovascular death" />
    <Mention id="M200" section="S1" type="Severity" start="7142" len="9" str="non-fatal" />
    <Mention id="M201" section="S1" type="AdverseReaction" start="7152" len="21" str="myocardial infarction" />
    <Mention id="M202" section="S1" type="Severity" start="7179" len="9" str="non-fatal" />
    <Mention id="M203" section="S1" type="AdverseReaction" start="7189" len="6" str="stroke" />
    <Mention id="M204" section="S1" type="AdverseReaction" start="8239" len="15" str="hepatic failure" />
    <Mention id="M205" section="S1" type="AdverseReaction" start="8261" len="5" str="fatal" />
    <Mention id="M206" section="S1" type="AdverseReaction" start="8269" len="8" str="jaundice" />
    <Mention id="M207" section="S1" type="Severity" start="8279" len="7" str="serious" />
    <Mention id="M208" section="S1" type="AdverseReaction" start="8296" len="23" str="abnormal liver function" />
    <Mention id="M209" section="S1" type="AdverseReaction" start="8334" len="14" str="liver disorder" />
    <Mention id="M210" section="S1" type="AdverseReaction" start="8382" len="11" str="anaphylaxis" />
    <Mention id="M211" section="S1" type="AdverseReaction" start="8395" len="21" str="anaphylactic reaction" />
    <Mention id="M212" section="S1" type="AdverseReaction" start="8474" len="14" str="rhabdomyolysis" />
    <Mention id="M213" section="S1" type="AdverseReaction" start="8520" len="18" str="psychotic behavior" />
    <Mention id="M214" section="S1" type="AdverseReaction" start="8549" len="19" str="aggressive thoughts" />
    <Mention id="M215" section="S1" type="AdverseReaction" start="8606" len="28" str="tubulointerstitial nephritis" />
    <Mention id="M216" section="S1" type="AdverseReaction" start="8683" len="16" str="generalized rash" />
    <Mention id="M217" section="S1" type="AdverseReaction" start="8701" len="24" str="Stevens Johnson Syndrome" />
    <Mention id="M218" section="S1" type="AdverseReaction" start="8727" len="31" str="hypersensitivity skin reactions" />
    <Mention id="M219" section="S2" type="AdverseReaction" start="55" len="10" str="Gout Flare" />
    <Mention id="M220" section="S2" type="AdverseReaction" start="83" len="11" str="gout flares" />
    <Mention id="M221" section="S2" type="AdverseReaction" start="441" len="21" str="Cardiovascular Events" />
    <Mention id="M222" section="S2" type="AdverseReaction" start="482" len="36" str="cardiovascular thromboembolic events" />
    <Mention id="M223" section="S2" type="AdverseReaction" start="668" len="15" str="Hepatic Effects" />
    <Mention id="M224" section="S2" type="AdverseReaction" start="710" len="15" str="hepatic failure" />
    <Mention id="M225" section="S2" type="AdverseReaction" start="737" len="5" str="fatal" />
    <Mention id="M226" section="S2" type="AdverseReaction" start="1106" len="11" str="gout flares" />
    <Mention id="M227" section="S2" type="AdverseReaction" start="1546" len="36" str="cardiovascular thromboembolic events" />
    <Mention id="M228" section="S2" type="AdverseReaction" start="1584" len="21" str="cardiovascular deaths" />
    <Mention id="M229" section="S2" type="Severity" start="1607" len="9" str="non-fatal" />
    <Mention id="M230" section="S2" type="AdverseReaction" start="1617" len="22" str="myocardial infarctions" />
    <Mention id="M231" section="S2" type="Severity" start="1645" len="9" str="non-fatal" />
    <Mention id="M232" section="S2" type="AdverseReaction" start="1655" len="7" str="strokes" />
    <Mention id="M233" section="S2" type="AdverseReaction" start="2054" len="5" str="fatal" />
    <Mention id="M234" section="S2" type="AdverseReaction" start="2074" len="15" str="hepatic failure" />
    <Mention id="M235" section="S2" type="AdverseReaction" start="2252" len="23" str="transaminase elevations" />
    <Mention id="M236" section="S2" type="Severity" start="2289" len="37" str="three times the upper limit of normal" />
  </Mentions>
  <Relations>
    <Relation id="RL1" type="Effect" arg1="M201" arg2="M200" />
    <Relation id="RL2" type="Effect" arg1="M203" arg2="M202" />
    <Relation id="RL3" type="Effect" arg1="M208" arg2="M207" />
    <Relation id="RL4" type="Effect" arg1="M230" arg2="M229" />
    <Relation id="RL5" type="Effect" arg1="M232" arg2="M231" />
    <Relation id="RL6" type="Effect" arg1="M235" arg2="M236" />
  </Relations>
  <Reactions>
    <Reaction id="AR1" str="liver function abnormalities">
      <Normalization id="AR1.N1" meddra_pt="Hepatic function abnormal" meddra_pt_id="10019670" meddra_llt="Function liver abnormal" meddra_llt_id="10017475" />
    </Reaction>
    <Reaction id="AR2" str="nausea">
      <Normalization id="AR2.N1" meddra_pt="Nausea" meddra_pt_id="10028813" />
    </Reaction>
    <Reaction id="AR3" str="arthralgia">
      <Normalization id="AR3.N1" meddra_pt="Arthralgia" meddra_pt_id="10003239" />
    </Reaction>
    <Reaction id="AR4" str="rash">
      <Normalization id="AR4.N1" meddra_pt="Rash" meddra_pt_id="10037844" />
    </Reaction>
    <Reaction id="AR5" str="dizziness">
      <Normalization id="AR5.N1" meddra_pt="Dizziness" meddra_pt_id="10013573" />
    </Reaction>
    <Reaction id="AR6" str="anemia">
      <Normalization id="AR6.N1" meddra_pt="Anaemia" meddra_pt_id="10002034" meddra_llt="Anemia" meddra_llt_id="10002272" />
    </Reaction>
    <Reaction id="AR7" str="idiopathic thrombocytopenic purpura">
      <Normalization id="AR7.N1" meddra_pt="Immune thrombocytopenic purpura" meddra_pt_id="10074667" meddra_llt="Idiopathic thrombocytopenic purpura" meddra_llt_id="10021245" />
    </Reaction>
    <Reaction id="AR8" str="leukocytosis">
      <Normalization id="AR8.N1" meddra_pt="Leukocytosis" meddra_pt_id="10024378" />
    </Reaction>
    <Reaction id="AR9" str="leukopenia">
      <Normalization id="AR9.N1" meddra_pt="Leukopenia" meddra_pt_id="10024384" />
    </Reaction>
    <Reaction id="AR10" str="neutropenia">
      <Normalization id="AR10.N1" meddra_pt="Neutropenia" meddra_pt_id="10029354" />
    </Reaction>
    <Reaction id="AR11" str="pancytopenia">
      <Normalization id="AR11.N1" meddra_pt="Pancytopenia" meddra_pt_id="10033661" />
    </Reaction>
    <Reaction id="AR12" str="splenomegaly">
      <Normalization id="AR12.N1" meddra_pt="Splenomegaly" meddra_pt_id="10041660" />
    </Reaction>
    <Reaction id="AR13" str="thrombocytopenia">
      <Normalization id="AR13.N1" meddra_pt="Thrombocytopenia" meddra_pt_id="10043554" />
    </Reaction>
    <Reaction id="AR14" str="angina pectoris">
      <Normalization id="AR14.N1" meddra_pt="Angina pectoris" meddra_pt_id="10002383" />
    </Reaction>
    <Reaction id="AR15" str="atrial fibrillation">
      <Normalization id="AR15.N1" meddra_pt="Atrial fibrillation" meddra_pt_id="10003658" />
    </Reaction>
    <Reaction id="AR16" str="atrial flutter">
      <Normalization id="AR16.N1" meddra_pt="Atrial flutter" meddra_pt_id="10003662" />
    </Reaction>
    <Reaction id="AR17" str="cardiac murmur">
      <Normalization id="AR17.N1" meddra_pt="Cardiac murmur" meddra_pt_id="10007586" />
    </Reaction>
    <Reaction id="AR18" str="ecg abnormal">
      <Normalization id="AR18.N1" meddra_pt="Electrocardiogram abnormal" meddra_pt_id="10014363" meddra_llt="ECG abnormal" meddra_llt_id="10014085" />
    </Reaction>
    <Reaction id="AR19" str="palpitations">
      <Normalization id="AR19.N1" meddra_pt="Palpitations" meddra_pt_id="10033557" />
    </Reaction>
    <Reaction id="AR20" str="sinus bradycardia">
      <Normalization id="AR20.N1" meddra_pt="Sinus bradycardia" meddra_pt_id="10040741" />
    </Reaction>
    <Reaction id="AR21" str="tachycardia">
      <Normalization id="AR21.N1" meddra_pt="Tachycardia" meddra_pt_id="10043071" />
    </Reaction>
    <Reaction id="AR22" str="deafness">
      <Normalization id="AR22.N1" meddra_pt="Deafness" meddra_pt_id="10011878" />
    </Reaction>
    <Reaction id="AR23" str="tinnitus">
      <Normalization id="AR23.N1" meddra_pt="Tinnitus" meddra_pt_id="10043882" />
    </Reaction>
    <Reaction id="AR24" str="vertigo">
      <Normalization id="AR24.N1" meddra_pt="Vertigo" meddra_pt_id="10047340" />
    </Reaction>
    <Reaction id="AR25" str="vision blurred">
      <Normalization id="AR25.N1" meddra_pt="Vision blurred" meddra_pt_id="10047513" />
    </Reaction>
    <Reaction id="AR26" str="abdominal distention">
      <Normalization id="AR26.N1" meddra_pt="Abdominal distension" meddra_pt_id="10000060" />
    </Reaction>
    <Reaction id="AR27" str="abdominal pain">
      <Normalization id="AR27.N1" meddra_pt="Abdominal pain" meddra_pt_id="10000081" />
    </Reaction>
    <Reaction id="AR28" str="constipation">
      <Normalization id="AR28.N1" meddra_pt="Constipation" meddra_pt_id="10010774" />
    </Reaction>
    <Reaction id="AR29" str="dry mouth">
      <Normalization id="AR29.N1" meddra_pt="Dry mouth" meddra_pt_id="10013781" />
    </Reaction>
    <Reaction id="AR30" str="dyspepsia">
      <Normalization id="AR30.N1" meddra_pt="Dyspepsia" meddra_pt_id="10013946" />
    </Reaction>
    <Reaction id="AR31" str="flatulence">
      <Normalization id="AR31.N1" meddra_pt="Flatulence" meddra_pt_id="10016766" />
    </Reaction>
    <Reaction id="AR32" str="frequent stools">
      <Normalization id="AR32.N1" meddra_pt="Frequent bowel movements" meddra_pt_id="10017367" meddra_llt="Increased stool frequency" meddra_llt_id="10048456" />
    </Reaction>
    <Reaction id="AR33" str="gastritis">
      <Normalization id="AR33.N1" meddra_pt="Gastritis" meddra_pt_id="10017853" />
    </Reaction>
    <Reaction id="AR34" str="gastroesophageal reflux disease">
      <Normalization id="AR34.N1" meddra_pt="Gastrooesophageal reflux disease" meddra_pt_id="10017885" meddra_llt="Gastroesophageal reflux disease" meddra_llt_id="10066874" />
    </Reaction>
    <Reaction id="AR35" str="gastrointestinal discomfort">
      <Normalization id="AR35.N1" meddra_pt="Abdominal discomfort" meddra_pt_id="10000059" meddra_llt="Gastrointestinal discomfort" meddra_llt_id="10054209" />
    </Reaction>
    <Reaction id="AR36" str="gingival pain">
      <Normalization id="AR36.N1" meddra_pt="Gingival pain" meddra_pt_id="10018286" />
    </Reaction>
    <Reaction id="AR37" str="haematemesis">
      <Normalization id="AR37.N1" meddra_pt="Haematemesis" meddra_pt_id="10018830" />
    </Reaction>
    <Reaction id="AR38" str="hyperchlorhydria">
      <Normalization id="AR38.N1" meddra_pt="Hyperchlorhydria" meddra_pt_id="10020601" />
    </Reaction>
    <Reaction id="AR39" str="hematochezia">
      <Normalization id="AR39.N1" meddra_pt="Haematochezia" meddra_pt_id="10018836" meddra_llt="Hematochezia" meddra_llt_id="10060544" />
    </Reaction>
    <Reaction id="AR40" str="mouth ulceration">
      <Normalization id="AR40.N1" meddra_pt="Mouth ulceration" meddra_pt_id="10028034" />
    </Reaction>
    <Reaction id="AR41" str="pancreatitis">
      <Normalization id="AR41.N1" meddra_pt="Pancreatitis" meddra_pt_id="10033645" />
    </Reaction>
    <Reaction id="AR42" str="peptic ulcer">
      <Normalization id="AR42.N1" meddra_pt="Peptic ulcer" meddra_pt_id="10034341" />
    </Reaction>
    <Reaction id="AR43" str="vomiting">
      <Normalization id="AR43.N1" meddra_pt="Vomiting" meddra_pt_id="10047700" />
    </Reaction>
    <Reaction id="AR44" str="asthenia">
      <Normalization id="AR44.N1" meddra_pt="Asthenia" meddra_pt_id="10003549" />
    </Reaction>
    <Reaction id="AR45" str="chest pain">
      <Normalization id="AR45.N1" meddra_pt="Chest pain" meddra_pt_id="10008479" />
    </Reaction>
    <Reaction id="AR46" str="chest discomfort">
      <Normalization id="AR46.N1" meddra_pt="Chest discomfort" meddra_pt_id="10008469" />
    </Reaction>
    <Reaction id="AR47" str="edema">
      <Normalization id="AR47.N1" meddra_pt="Oedema" meddra_pt_id="10030095" meddra_llt="Edema" meddra_llt_id="10014210" />
    </Reaction>
    <Reaction id="AR48" str="fatigue">
      <Normalization id="AR48.N1" meddra_pt="Fatigue" meddra_pt_id="10016256" />
    </Reaction>
    <Reaction id="AR49" str="feeling abnormal">
      <Normalization id="AR49.N1" meddra_pt="Feeling abnormal" meddra_pt_id="10016322" />
    </Reaction>
    <Reaction id="AR50" str="gait disturbance">
      <Normalization id="AR50.N1" meddra_pt="Gait disturbance" meddra_pt_id="10017577" />
    </Reaction>
    <Reaction id="AR51" str="influenza-like symptoms">
      <Normalization id="AR51.N1" meddra_pt="Influenza like illness" meddra_pt_id="10022004" meddra_llt="Influenza-like symptoms" meddra_llt_id="10022009" />
    </Reaction>
    <Reaction id="AR52" str="mass">
      <Normalization id="AR52.N1" meddra_pt="Mass" meddra_pt_id="10026865" />
    </Reaction>
    <Reaction id="AR53" str="pain">
      <Normalization id="AR53.N1" meddra_pt="Pain" meddra_pt_id="10033371" />
    </Reaction>
    <Reaction id="AR54" str="thirst">
      <Normalization id="AR54.N1" meddra_pt="Thirst" meddra_pt_id="10043458" />
    </Reaction>
    <Reaction id="AR55" str="cholelithiasis">
      <Normalization id="AR55.N1" meddra_pt="Cholelithiasis" meddra_pt_id="10008629" />
    </Reaction>
    <Reaction id="AR56" str="cholecystitis">
      <Normalization id="AR56.N1" meddra_pt="Cholecystitis" meddra_pt_id="10008612" />
    </Reaction>
    <Reaction id="AR57" str="hepatic steatosis">
      <Normalization id="AR57.N1" meddra_pt="Hepatic steatosis" meddra_pt_id="10019708" />
    </Reaction>
    <Reaction id="AR58" str="hepatitis">
      <Normalization id="AR58.N1" meddra_pt="Hepatitis" meddra_pt_id="10019717" />
    </Reaction>
    <Reaction id="AR59" str="hepatomegaly">
      <Normalization id="AR59.N1" meddra_pt="Hepatomegaly" meddra_pt_id="10019842" />
    </Reaction>
    <Reaction id="AR60" str="hypersensitivity">
      <Normalization id="AR60.N1" meddra_pt="Hypersensitivity" meddra_pt_id="10020751" />
    </Reaction>
    <Reaction id="AR61" str="herpes zoster">
      <Normalization id="AR61.N1" meddra_pt="Herpes zoster" meddra_pt_id="10019974" />
    </Reaction>
    <Reaction id="AR62" str="contusion">
      <Normalization id="AR62.N1" meddra_pt="Contusion" meddra_pt_id="10050584" />
    </Reaction>
    <Reaction id="AR63" str="anorexia">
      <Normalization id="AR63.N1" meddra_pt="Decreased appetite" meddra_pt_id="10061428" meddra_llt="Anorexia" meddra_llt_id="10002646" />
    </Reaction>
    <Reaction id="AR64" str="appetite decreased">
      <Normalization id="AR64.N1" meddra_pt="Decreased appetite" meddra_pt_id="10061428" meddra_llt="Appetite decreased NOS" meddra_llt_id="10003020" />
    </Reaction>
    <Reaction id="AR65" str="appetite increased">
      <Normalization id="AR65.N1" meddra_pt="Increased appetite" meddra_pt_id="10021654" />
    </Reaction>
    <Reaction id="AR66" str="dehydration">
      <Normalization id="AR66.N1" meddra_pt="Dehydration" meddra_pt_id="10012174" />
    </Reaction>
    <Reaction id="AR67" str="diabetes mellitus">
      <Normalization id="AR67.N1" meddra_pt="Diabetes mellitus" meddra_pt_id="10012601" />
    </Reaction>
    <Reaction id="AR68" str="hypercholesterolemia">
      <Normalization id="AR68.N1" meddra_pt="Hypercholesterolaemia" meddra_pt_id="10020603" meddra_llt="Hypercholesterolemia" meddra_llt_id="10020604" />
    </Reaction>
    <Reaction id="AR69" str="hyperglycemia">
      <Normalization id="AR69.N1" meddra_pt="Hyperglycaemia" meddra_pt_id="10020635" meddra_llt="Hyperglycemia" meddra_llt_id="10020639" />
    </Reaction>
    <Reaction id="AR70" str="hyperlipidemia">
      <Normalization id="AR70.N1" meddra_pt="Hyperlipidaemia" meddra_pt_id="10062060" meddra_llt="Hyperlipidemia" meddra_llt_id="10020667" />
    </Reaction>
    <Reaction id="AR71" str="hypertriglyceridemia">
      <Normalization id="AR71.N1" meddra_pt="Hypertriglyceridaemia" meddra_pt_id="10020869" meddra_llt="Hypertriglyceridemia" meddra_llt_id="10020870" />
    </Reaction>
    <Reaction id="AR72" str="hypokalemia">
      <Normalization id="AR72.N1" meddra_pt="Hypokalaemia" meddra_pt_id="10021015" meddra_llt="Hypokalemia" meddra_llt_id="10021018" />
    </Reaction>
    <Reaction id="AR73" str="weight decreased">
      <Normalization id="AR73.N1" meddra_pt="Weight decreased" meddra_pt_id="10047895" />
    </Reaction>
    <Reaction id="AR74" str="weight increased">
      <Normalization id="AR74.N1" meddra_pt="Weight increased" meddra_pt_id="10047899" />
    </Reaction>
    <Reaction id="AR75" str="arthritis">
      <Normalization id="AR75.N1" meddra_pt="Arthritis" meddra_pt_id="10003246" />
    </Reaction>
    <Reaction id="AR76" str="joint stiffness">
      <Normalization id="AR76.N1" meddra_pt="Joint stiffness" meddra_pt_id="10023230" />
    </Reaction>
    <Reaction id="AR77" str="joint swelling">
      <Normalization id="AR77.N1" meddra_pt="Joint swelling" meddra_pt_id="10023232" />
    </Reaction>
    <Reaction id="AR78" str="muscle spasms">
      <Normalization id="AR78.N1" meddra_pt="Muscle spasms" meddra_pt_id="10028334" />
    </Reaction>
    <Reaction id="AR79" str="muscle twitching">
      <Normalization id="AR79.N1" meddra_pt="Muscle twitching" meddra_pt_id="10028347" />
    </Reaction>
    <Reaction id="AR80" str="muscle tightness">
      <Normalization id="AR80.N1" meddra_pt="Muscle tightness" meddra_pt_id="10049816" />
    </Reaction>
    <Reaction id="AR81" str="muscle weakness">
      <Normalization id="AR81.N1" meddra_pt="Muscular weakness" meddra_pt_id="10028372" meddra_llt="Muscle weakness" meddra_llt_id="10028350" />
    </Reaction>
    <Reaction id="AR82" str="musculoskeletal pain">
      <Normalization id="AR82.N1" meddra_pt="Musculoskeletal pain" meddra_pt_id="10028391" />
    </Reaction>
    <Reaction id="AR83" str="musculoskeletal stiffness">
      <Normalization id="AR83.N1" meddra_pt="Musculoskeletal stiffness" meddra_pt_id="10052904" />
    </Reaction>
    <Reaction id="AR84" str="myalgia">
      <Normalization id="AR84.N1" meddra_pt="Myalgia" meddra_pt_id="10028411" />
    </Reaction>
    <Reaction id="AR85" str="altered taste">
      <Normalization id="AR85.N1" meddra_pt="Dysgeusia" meddra_pt_id="10013911" meddra_llt="Taste altered" meddra_llt_id="10043126" />
    </Reaction>
    <Reaction id="AR86" str="balance disorder">
      <Normalization id="AR86.N1" meddra_pt="Balance disorder" meddra_pt_id="10049848" />
    </Reaction>
    <Reaction id="AR87" str="cerebrovascular accident">
      <Normalization id="AR87.N1" meddra_pt="Cerebrovascular accident" meddra_pt_id="10008190" />
    </Reaction>
    <Reaction id="AR88" str="guillain-barre syndrome">
      <Normalization id="AR88.N1" meddra_pt="Guillain-Barre syndrome" meddra_pt_id="10018767" />
    </Reaction>
    <Reaction id="AR89" str="headache">
      <Normalization id="AR89.N1" meddra_pt="Headache" meddra_pt_id="10019211" />
    </Reaction>
    <Reaction id="AR90" str="hemiparesis">
      <Normalization id="AR90.N1" meddra_pt="Hemiparesis" meddra_pt_id="10019465" />
    </Reaction>
    <Reaction id="AR91" str="hypoesthesia">
      <Normalization id="AR91.N1" meddra_pt="Hypoaesthesia" meddra_pt_id="10020937" meddra_llt="Hypoesthesia" meddra_llt_id="10020976" />
    </Reaction>
    <Reaction id="AR92" str="hyposmia">
      <Normalization id="AR92.N1" meddra_pt="Hyposmia" meddra_pt_id="10050515" />
    </Reaction>
    <Reaction id="AR93" str="lacunar infarction">
      <Normalization id="AR93.N1" meddra_pt="Lacunar infarction" meddra_pt_id="10051078" />
    </Reaction>
    <Reaction id="AR94" str="lethargy">
      <Normalization id="AR94.N1" meddra_pt="Lethargy" meddra_pt_id="10024264" />
    </Reaction>
    <Reaction id="AR95" str="mental impairment">
      <Normalization id="AR95.N1" meddra_pt="Mental impairment" meddra_pt_id="10027374" />
    </Reaction>
    <Reaction id="AR96" str="migraine">
      <Normalization id="AR96.N1" meddra_pt="Migraine" meddra_pt_id="10027599" />
    </Reaction>
    <Reaction id="AR97" str="paresthesia">
      <Normalization id="AR97.N1" meddra_pt="Paraesthesia" meddra_pt_id="10033775" meddra_llt="Paresthesia" meddra_llt_id="10033987" />
    </Reaction>
    <Reaction id="AR98" str="somnolence">
      <Normalization id="AR98.N1" meddra_pt="Somnolence" meddra_pt_id="10041349" />
    </Reaction>
    <Reaction id="AR99" str="transient ischemic attack">
      <Normalization id="AR99.N1" meddra_pt="Transient ischaemic attack" meddra_pt_id="10044390" meddra_llt="Transient ischemic attack" meddra_llt_id="10072760" />
    </Reaction>
    <Reaction id="AR100" str="tremor">
      <Normalization id="AR100.N1" meddra_pt="Tremor" meddra_pt_id="10044565" />
    </Reaction>
    <Reaction id="AR101" str="agitation">
      <Normalization id="AR101.N1" meddra_pt="Agitation" meddra_pt_id="10001497" />
    </Reaction>
    <Reaction id="AR102" str="anxiety">
      <Normalization id="AR102.N1" meddra_pt="Anxiety" meddra_pt_id="10002855" />
    </Reaction>
    <Reaction id="AR103" str="depression">
      <Normalization id="AR103.N1" meddra_pt="Depression" meddra_pt_id="10012378" />
    </Reaction>
    <Reaction id="AR104" str="insomnia">
      <Normalization id="AR104.N1" meddra_pt="Insomnia" meddra_pt_id="10022437" />
    </Reaction>
    <Reaction id="AR105" str="irritability">
      <Normalization id="AR105.N1" meddra_pt="Irritability" meddra_pt_id="10022998" />
    </Reaction>
    <Reaction id="AR106" str="libido decreased">
      <Normalization id="AR106.N1" meddra_pt="Libido decreased" meddra_pt_id="10024419" />
    </Reaction>
    <Reaction id="AR107" str="nervousness">
      <Normalization id="AR107.N1" meddra_pt="Nervousness" meddra_pt_id="10029216" />
    </Reaction>
    <Reaction id="AR108" str="panic attack">
      <Normalization id="AR108.N1" meddra_pt="Panic attack" meddra_pt_id="10033664" />
    </Reaction>
    <Reaction id="AR109" str="personality change">
      <Normalization id="AR109.N1" meddra_pt="Personality change" meddra_pt_id="10034719" />
    </Reaction>
    <Reaction id="AR110" str="urinary urgency">
      <Normalization id="AR110.N1" meddra_pt="Micturition urgency" meddra_pt_id="10027566" meddra_llt="Urinary urgency" meddra_llt_id="10046593" />
    </Reaction>
    <Reaction id="AR111" str="urinary incontinence">
      <Normalization id="AR111.N1" meddra_pt="Urinary incontinence" meddra_pt_id="10046543" />
    </Reaction>
    <Reaction id="AR112" str="hematuria">
      <Normalization id="AR112.N1" meddra_pt="Haematuria" meddra_pt_id="10018867" meddra_llt="Hematuria" meddra_llt_id="10019450" />
    </Reaction>
    <Reaction id="AR113" str="nephrolithiasis">
      <Normalization id="AR113.N1" meddra_pt="Nephrolithiasis" meddra_pt_id="10029148" />
    </Reaction>
    <Reaction id="AR114" str="pollakiuria">
      <Normalization id="AR114.N1" meddra_pt="Pollakiuria" meddra_pt_id="10036018" />
    </Reaction>
    <Reaction id="AR115" str="proteinuria">
      <Normalization id="AR115.N1" meddra_pt="Proteinuria" meddra_pt_id="10037032" />
    </Reaction>
    <Reaction id="AR116" str="renal failure">
      <Normalization id="AR116.N1" meddra_pt="Renal failure" meddra_pt_id="10038435" />
    </Reaction>
    <Reaction id="AR117" str="renal insufficiency">
      <Normalization id="AR117.N1" meddra_pt="Renal failure" meddra_pt_id="10038435" meddra_llt="Renal insufficiency" meddra_llt_id="10038474" />
    </Reaction>
    <Reaction id="AR118" str="breast pain">
      <Normalization id="AR118.N1" meddra_pt="Breast pain" meddra_pt_id="10006298" />
    </Reaction>
    <Reaction id="AR119" str="erectile dysfunction">
      <Normalization id="AR119.N1" meddra_pt="Erectile dysfunction" meddra_pt_id="10061461" />
    </Reaction>
    <Reaction id="AR120" str="gynecomastia">
      <Normalization id="AR120.N1" meddra_pt="Gynaecomastia" meddra_pt_id="10018800" meddra_llt="Gynecomastia" meddra_llt_id="10018801" />
    </Reaction>
    <Reaction id="AR121" str="bronchitis">
      <Normalization id="AR121.N1" meddra_pt="Bronchitis" meddra_pt_id="10006451" />
    </Reaction>
    <Reaction id="AR122" str="cough">
      <Normalization id="AR122.N1" meddra_pt="Cough" meddra_pt_id="10011224" />
    </Reaction>
    <Reaction id="AR123" str="dyspnea">
      <Normalization id="AR123.N1" meddra_pt="Dyspnoea" meddra_pt_id="10013968" meddra_llt="Dyspnea" meddra_llt_id="10013963" />
    </Reaction>
    <Reaction id="AR124" str="epistaxis">
      <Normalization id="AR124.N1" meddra_pt="Epistaxis" meddra_pt_id="10015090" />
    </Reaction>
    <Reaction id="AR125" str="nasal dryness">
      <Normalization id="AR125.N1" meddra_pt="Nasal dryness" meddra_pt_id="10028740" />
    </Reaction>
    <Reaction id="AR126" str="paranasal sinus hypersecretion">
      <Normalization id="AR126.N1" meddra_pt="Paranasal sinus hypersecretion" meddra_pt_id="10057392" />
    </Reaction>
    <Reaction id="AR127" str="pharyngeal edema">
      <Normalization id="AR127.N1" meddra_pt="Pharyngeal oedema" meddra_pt_id="10034829" meddra_llt="Pharyngeal edema" meddra_llt_id="10054544" />
    </Reaction>
    <Reaction id="AR128" str="respiratory tract congestion">
      <Normalization id="AR128.N1" meddra_pt="Respiratory tract congestion" meddra_pt_id="10052251" />
    </Reaction>
    <Reaction id="AR129" str="sneezing">
      <Normalization id="AR129.N1" meddra_pt="Sneezing" meddra_pt_id="10041232" />
    </Reaction>
    <Reaction id="AR130" str="throat irritation">
      <Normalization id="AR130.N1" meddra_pt="Throat irritation" meddra_pt_id="10043521" />
    </Reaction>
    <Reaction id="AR131" str="upper respiratory tract infection">
      <Normalization id="AR131.N1" meddra_pt="Upper respiratory tract infection" meddra_pt_id="10046306" />
    </Reaction>
    <Reaction id="AR132" str="alopecia">
      <Normalization id="AR132.N1" meddra_pt="Alopecia" meddra_pt_id="10001760" />
    </Reaction>
    <Reaction id="AR133" str="angio-edema">
      <Normalization id="AR133.N1" meddra_pt="Angioedema" meddra_pt_id="10002424" meddra_llt="Angio-edema" meddra_llt_id="10002394" />
    </Reaction>
    <Reaction id="AR134" str="dermatitis">
      <Normalization id="AR134.N1" meddra_pt="Dermatitis" meddra_pt_id="10012431" />
    </Reaction>
    <Reaction id="AR135" str="dermographism">
      <Normalization id="AR135.N1" meddra_pt="Mechanical urticaria" meddra_pt_id="10068773" meddra_llt="Dermographism" meddra_llt_id="10012521" />
    </Reaction>
    <Reaction id="AR136" str="ecchymosis">
      <Normalization id="AR136.N1" meddra_pt="Ecchymosis" meddra_pt_id="10014080" />
    </Reaction>
    <Reaction id="AR137" str="eczema">
      <Normalization id="AR137.N1" meddra_pt="Eczema" meddra_pt_id="10014184" />
    </Reaction>
    <Reaction id="AR138" str="hair color changes">
      <Normalization id="AR138.N1" meddra_pt="Hair colour changes" meddra_pt_id="10019030" meddra_llt="Hair color changes" meddra_llt_id="10055525" />
    </Reaction>
    <Reaction id="AR139" str="hair growth abnormal">
      <Normalization id="AR139.N1" meddra_pt="Hair growth abnormal" meddra_pt_id="10019044" />
    </Reaction>
    <Reaction id="AR140" str="hyperhidrosis">
      <Normalization id="AR140.N1" meddra_pt="Hyperhidrosis" meddra_pt_id="10020642" />
    </Reaction>
    <Reaction id="AR141" str="peeling skin">
      <Normalization id="AR141.N1" meddra_pt="Skin exfoliation" meddra_pt_id="10040844" meddra_llt="Skin peeling" meddra_llt_id="10040908" />
    </Reaction>
    <Reaction id="AR142" str="petechiae">
      <Normalization id="AR142.N1" meddra_pt="Petechiae" meddra_pt_id="10034754" />
    </Reaction>
    <Reaction id="AR143" str="photosensitivity">
      <Normalization id="AR143.N1" meddra_pt="Photosensitivity reaction" meddra_pt_id="10034972" meddra_llt="Photosensitivity" meddra_llt_id="10034966" />
    </Reaction>
    <Reaction id="AR144" str="pruritus">
      <Normalization id="AR144.N1" meddra_pt="Pruritus" meddra_pt_id="10037087" />
    </Reaction>
    <Reaction id="AR145" str="purpura">
      <Normalization id="AR145.N1" meddra_pt="Purpura" meddra_pt_id="10037549" />
    </Reaction>
    <Reaction id="AR146" str="skin discoloration">
      <Normalization id="AR146.N1" meddra_pt="Skin discolouration" meddra_pt_id="10040829" meddra_llt="Skin discoloration" meddra_llt_id="10040828" />
    </Reaction>
    <Reaction id="AR147" str="skin altered pigmentation">
      <Normalization id="AR147.N1" meddra_pt="Pigmentation disorder" meddra_pt_id="10062080" meddra_llt="Pigmentation skin" meddra_llt_id="10035028" />
    </Reaction>
    <Reaction id="AR148" str="skin lesion">
      <Normalization id="AR148.N1" meddra_pt="Skin lesion" meddra_pt_id="10040882" />
    </Reaction>
    <Reaction id="AR149" str="skin odor abnormal">
      <Normalization id="AR149.N1" meddra_pt="Skin odour abnormal" meddra_pt_id="10040904" meddra_llt="Skin odor abnormal" meddra_llt_id="10040903" />
    </Reaction>
    <Reaction id="AR150" str="urticaria">
      <Normalization id="AR150.N1" meddra_pt="Urticaria" meddra_pt_id="10046735" />
    </Reaction>
    <Reaction id="AR151" str="flushing">
      <Normalization id="AR151.N1" meddra_pt="Flushing" meddra_pt_id="10016825" />
    </Reaction>
    <Reaction id="AR152" str="hot flush">
      <Normalization id="AR152.N1" meddra_pt="Hot flush" meddra_pt_id="10060800" />
    </Reaction>
    <Reaction id="AR153" str="hypertension">
      <Normalization id="AR153.N1" meddra_pt="Hypertension" meddra_pt_id="10020772" />
    </Reaction>
    <Reaction id="AR154" str="hypotension">
      <Normalization id="AR154.N1" meddra_pt="Hypotension" meddra_pt_id="10021097" />
    </Reaction>
    <Reaction id="AR155" str="activated partial thromboplastin time prolonged">
      <Normalization id="AR155.N1" meddra_pt="Activated partial thromboplastin time prolonged" meddra_pt_id="10000636" />
    </Reaction>
    <Reaction id="AR156" str="creatine increased">
      <Normalization id="AR156.N1" meddra_pt="Blood creatine increased" meddra_pt_id="10005464" meddra_llt="Creatine increased" meddra_llt_id="10011333" />
    </Reaction>
    <Reaction id="AR157" str="bicarbonate decreased">
      <Normalization id="AR157.N1" meddra_pt="Blood bicarbonate decreased" meddra_pt_id="10005359" />
    </Reaction>
    <Reaction id="AR158" str="sodium increased">
      <Normalization id="AR158.N1" meddra_pt="Blood sodium increased" meddra_pt_id="10005803" meddra_llt="Sodium increased" meddra_llt_id="10041272" />
    </Reaction>
    <Reaction id="AR159" str="eeg abnormal">
      <Normalization id="AR159.N1" meddra_pt="Electroencephalogram abnormal" meddra_pt_id="10014408" meddra_llt="EEG abnormal" meddra_llt_id="10014276" />
    </Reaction>
    <Reaction id="AR160" str="glucose increased">
      <Normalization id="AR160.N1" meddra_pt="Blood glucose increased" meddra_pt_id="10005557" meddra_llt="Glucose increased" meddra_llt_id="10018421" />
    </Reaction>
    <Reaction id="AR161" str="cholesterol increased">
      <Normalization id="AR161.N1" meddra_pt="Blood cholesterol increased" meddra_pt_id="10005425" meddra_llt="Cholesterol levels raised" meddra_llt_id="10008663" />
    </Reaction>
    <Reaction id="AR162" str="triglycerides increased">
      <Normalization id="AR162.N1" meddra_pt="Blood triglycerides increased" meddra_pt_id="10005839" meddra_llt="Triglycerides high" meddra_llt_id="10052373" />
    </Reaction>
    <Reaction id="AR163" str="amylase increased">
      <Normalization id="AR163.N1" meddra_pt="Amylase increased" meddra_pt_id="10002016" />
    </Reaction>
    <Reaction id="AR164" str="potassium increased">
      <Normalization id="AR164.N1" meddra_pt="Blood potassium increased" meddra_pt_id="10005725" meddra_llt="Potassium increased" meddra_llt_id="10036450" />
    </Reaction>
    <Reaction id="AR165" str="tsh increased">
      <Normalization id="AR165.N1" meddra_pt="Blood thyroid stimulating hormone increased" meddra_pt_id="10005833" meddra_llt="TSH increased" meddra_llt_id="10044718" />
    </Reaction>
    <Reaction id="AR166" str="platelet count decreased">
      <Normalization id="AR166.N1" meddra_pt="Platelet count decreased" meddra_pt_id="10035528" />
    </Reaction>
    <Reaction id="AR167" str="hematocrit decreased">
      <Normalization id="AR167.N1" meddra_pt="Haematocrit decreased" meddra_pt_id="10018838" meddra_llt="Hematocrit decreased" meddra_llt_id="10019423" />
    </Reaction>
    <Reaction id="AR168" str="hemoglobin decreased">
      <Normalization id="AR168.N1" meddra_pt="Haemoglobin decreased" meddra_pt_id="10018884" meddra_llt="Hemoglobin decreased" meddra_llt_id="10019483" />
    </Reaction>
    <Reaction id="AR169" str="mcv increased">
      <Normalization id="AR169.N1" meddra_pt="Mean cell volume increased" meddra_pt_id="10027004" />
    </Reaction>
    <Reaction id="AR170" str="rbc decreased">
      <Normalization id="AR170.N1" meddra_pt="Red blood cell count decreased" meddra_pt_id="10038153" meddra_llt="RBC decreased" meddra_llt_id="10037926" />
    </Reaction>
    <Reaction id="AR171" str="creatinine increased">
      <Normalization id="AR171.N1" meddra_pt="Blood creatinine increased" meddra_pt_id="10005483" meddra_llt="Creatinine increased" meddra_llt_id="10011368" />
    </Reaction>
    <Reaction id="AR172" str="blood urea increased">
      <Normalization id="AR172.N1" meddra_pt="Blood urea increased" meddra_pt_id="10005851" />
    </Reaction>
    <Reaction id="AR173" str="bun/creatinine ratio increased">
      <Normalization id="AR173.N1" meddra_pt="Blood urea nitrogen/creatinine ratio increased" meddra_pt_id="10050760" />
    </Reaction>
    <Reaction id="AR174" str="creatine phosphokinase increased">
      <Normalization id="AR174.N1" meddra_pt="Blood creatine phosphokinase increased" meddra_pt_id="10005470" meddra_llt="Creatine phosphokinase increased" meddra_llt_id="10011349" />
    </Reaction>
    <Reaction id="AR175" str="cpk increased">
      <Normalization id="AR175.N1" meddra_pt="Blood creatine phosphokinase increased" meddra_pt_id="10005470" meddra_llt="CPK increased" meddra_llt_id="10011268" />
    </Reaction>
    <Reaction id="AR176" str="alkaline phosphatase increased">
      <Normalization id="AR176.N1" meddra_pt="Blood alkaline phosphatase increased" meddra_pt_id="10059570" meddra_llt="Alkaline phosphatase increased" meddra_llt_id="10001675" />
    </Reaction>
    <Reaction id="AR177" str="ldh increased">
      <Normalization id="AR177.N1" meddra_pt="Blood lactate dehydrogenase increased" meddra_pt_id="10005630" meddra_llt="LDH increased" meddra_llt_id="10024051" />
    </Reaction>
    <Reaction id="AR178" str="psa increased">
      <Normalization id="AR178.N1" meddra_pt="Prostatic specific antigen increased" meddra_pt_id="10036975" meddra_llt="PSA increased" meddra_llt_id="10037102" />
    </Reaction>
    <Reaction id="AR179" str="urine output increased">
      <Normalization id="AR179.N1" meddra_pt="Urine output increased" meddra_pt_id="10059896" />
    </Reaction>
    <Reaction id="AR180" str="urine output decreased">
      <Normalization id="AR180.N1" meddra_pt="Urine output decreased" meddra_pt_id="10059895" />
    </Reaction>
    <Reaction id="AR181" str="lymphocyte count decreased">
      <Normalization id="AR181.N1" meddra_pt="Lymphocyte count decreased" meddra_pt_id="10025256" />
    </Reaction>
    <Reaction id="AR182" str="neutrophil count decreased">
      <Normalization id="AR182.N1" meddra_pt="Neutrophil count decreased" meddra_pt_id="10029366" />
    </Reaction>
    <Reaction id="AR183" str="wbc increased">
      <Normalization id="AR183.N1" meddra_pt="White blood cell count increased" meddra_pt_id="10047943" meddra_llt="WBC increased" meddra_llt_id="10056739" />
    </Reaction>
    <Reaction id="AR184" str="wbc decreased">
      <Normalization id="AR184.N1" meddra_pt="White blood cell count decreased" meddra_pt_id="10047942" meddra_llt="WBC decreased" meddra_llt_id="10056731" />
    </Reaction>
    <Reaction id="AR185" str="coagulation test abnormal">
      <Normalization id="AR185.N1" meddra_pt="Coagulation test abnormal" meddra_pt_id="10063557" />
    </Reaction>
    <Reaction id="AR186" str="low density lipoprotein increased">
      <Normalization id="AR186.N1" meddra_pt="Low density lipoprotein increased" meddra_pt_id="10024910" />
    </Reaction>
    <Reaction id="AR187" str="ldl increased">
      <Normalization id="AR187.N1" meddra_pt="Low density lipoprotein increased" meddra_pt_id="10024910" meddra_llt="LDL increased" meddra_llt_id="10024057" />
    </Reaction>
    <Reaction id="AR188" str="prothrombin time prolonged">
      <Normalization id="AR188.N1" meddra_pt="Prothrombin time prolonged" meddra_pt_id="10037063" />
    </Reaction>
    <Reaction id="AR189" str="urinary casts">
      <Normalization id="AR189.N1" meddra_pt="Urinary casts present" meddra_pt_id="10067534" />
    </Reaction>
    <Reaction id="AR190" str="urine positive for white blood cells">
      <Normalization id="AR190.N1" meddra_pt="White blood cells urine positive" meddra_pt_id="10047967" />
    </Reaction>
    <Reaction id="AR191" str="urine positive for protein">
      <Normalization id="AR191.N1" meddra_pt="Protein urine present" meddra_pt_id="10053123" meddra_llt="Protein urine positive" meddra_llt_id="10037020" />
    </Reaction>
    <Reaction id="AR192" str="cardiovascular events">
      <Normalization id="AR192.N1" meddra_pt="Cardiovascular symptom" meddra_pt_id="10075534" />
    </Reaction>
    <Reaction id="AR193" str="deaths">
      <Normalization id="AR193.N1" meddra_pt="Death" meddra_pt_id="10011906" />
    </Reaction>
    <Reaction id="AR194" str="cardiovascular death">
      <Normalization id="AR194.N1" meddra_pt="Cardiac death" meddra_pt_id="10049993" />
    </Reaction>
    <Reaction id="AR195" str="myocardial infarction">
      <Normalization id="AR195.N1" meddra_pt="Myocardial infarction" meddra_pt_id="10028596" />
    </Reaction>
    <Reaction id="AR196" str="stroke">
      <Normalization id="AR196.N1" meddra_pt="Cerebrovascular accident" meddra_pt_id="10008190" meddra_llt="Stroke" meddra_llt_id="10042244" />
    </Reaction>
    <Reaction id="AR197" str="hepatic failure">
      <Normalization id="AR197.N1" meddra_pt="Hepatic failure" meddra_pt_id="10019663" />
    </Reaction>
    <Reaction id="AR198" str="fatal">
      <Normalization id="AR198.N1" meddra_pt="Death" meddra_pt_id="10011906" />
    </Reaction>
    <Reaction id="AR199" str="jaundice">
      <Normalization id="AR199.N1" meddra_pt="Jaundice" meddra_pt_id="10023126" />
    </Reaction>
    <Reaction id="AR200" str="abnormal liver function">
      <Normalization id="AR200.N1" meddra_pt="Hepatic function abnormal" meddra_pt_id="10019670" meddra_llt="Function liver abnormal" meddra_llt_id="10017475" />
    </Reaction>
    <Reaction id="AR201" str="liver disorder">
      <Normalization id="AR201.N1" meddra_pt="Liver disorder" meddra_pt_id="10024670" />
    </Reaction>
    <Reaction id="AR202" str="anaphylaxis">
      <Normalization id="AR202.N1" meddra_pt="Anaphylactic reaction" meddra_pt_id="10002198" meddra_llt="Anaphylaxis" meddra_llt_id="10002218" />
    </Reaction>
    <Reaction id="AR203" str="anaphylactic reaction">
      <Normalization id="AR203.N1" meddra_pt="Anaphylactic reaction" meddra_pt_id="10002198" />
    </Reaction>
    <Reaction id="AR204" str="rhabdomyolysis">
      <Normalization id="AR204.N1" meddra_pt="Rhabdomyolysis" meddra_pt_id="10039020" />
    </Reaction>
    <Reaction id="AR205" str="psychotic behavior">
      <Normalization id="AR205.N1" meddra_pt="Psychotic behaviour" meddra_pt_id="10037249" meddra_llt="Psychotic behavior" meddra_llt_id="10067568" />
    </Reaction>
    <Reaction id="AR206" str="aggressive thoughts">
      <Normalization id="AR206.N1" meddra_pt="Aggression" meddra_pt_id="10001488" meddra_llt="Aggressive reaction" meddra_llt_id="10001493" />
    </Reaction>
    <Reaction id="AR207" str="tubulointerstitial nephritis">
      <Normalization id="AR207.N1" meddra_pt="Tubulointerstitial nephritis" meddra_pt_id="10048302" />
    </Reaction>
    <Reaction id="AR208" str="generalized rash">
      <Normalization id="AR208.N1" meddra_pt="Rash generalised" meddra_pt_id="10037858" meddra_llt="Generalized rash" meddra_llt_id="10049201" />
    </Reaction>
    <Reaction id="AR209" str="stevens johnson syndrome">
      <Normalization id="AR209.N1" meddra_pt="Stevens-Johnson syndrome" meddra_pt_id="10042033" meddra_llt="Stevens Johnson syndrome" meddra_llt_id="10042030" />
    </Reaction>
    <Reaction id="AR210" str="hypersensitivity skin reactions">
      <Normalization id="AR210.N1" meddra_pt="Dermatitis allergic" meddra_pt_id="10012434" meddra_llt="Cutaneous hypersensitivity" meddra_llt_id="10011667" />
    </Reaction>
    <Reaction id="AR211" str="gout flare">
      <Normalization id="AR211.N1" meddra_pt="Gout" meddra_pt_id="10018627" meddra_llt="Gout flare" meddra_llt_id="10064900" />
    </Reaction>
    <Reaction id="AR212" str="gout flares">
      <Normalization id="AR212.N1" meddra_pt="Gout" meddra_pt_id="10018627" meddra_llt="Gout flare" meddra_llt_id="10064900" />
    </Reaction>
    <Reaction id="AR213" str="cardiovascular thromboembolic events">
      <Normalization id="AR213.N1" meddra_pt="Embolism" meddra_pt_id="10061169" meddra_llt="Thromboembolic event" meddra_llt_id="10043565" />
    </Reaction>
    <Reaction id="AR214" str="hepatic effects">
      <Normalization id="AR214.N1" meddra_pt="Hepatotoxicity" meddra_pt_id="10019851" meddra_llt="Hepatotoxic effect" meddra_llt_id="10019850" />
    </Reaction>
    <Reaction id="AR215" str="cardiovascular deaths">
      <Normalization id="AR215.N1" meddra_pt="Cardiac death" meddra_pt_id="10049993" />
    </Reaction>
    <Reaction id="AR216" str="myocardial infarctions">
      <Normalization id="AR216.N1" meddra_pt="Myocardial infarction" meddra_pt_id="10028596" />
    </Reaction>
    <Reaction id="AR217" str="strokes">
      <Normalization id="AR217.N1" meddra_pt="Cerebrovascular accident" meddra_pt_id="10008190" meddra_llt="Stroke" meddra_llt_id="10042244" />
    </Reaction>
    <Reaction id="AR218" str="transaminase elevations">
      <Normalization id="AR218.N1" meddra_pt="Transaminases increased" meddra_pt_id="10054889" />
    </Reaction>
  </Reactions>
</Label>
